NASDAQ:SMLR Semler Scientific (SMLR) Stock Price, News & Analysis $38.08 -0.81 (-2.08%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$38.02 -0.06 (-0.17%) As of 07/25/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Semler Scientific Stock (NASDAQ:SMLR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Semler Scientific alerts:Sign Up Key Stats Today's Range$36.02▼$38.5050-Day Range$28.53▼$45.9752-Week Range$21.77▼$81.56Volume633,295 shsAverage Volume742,577 shsMarket Capitalization$525.05 millionP/E RatioN/ADividend YieldN/APrice Target$89.00Consensus RatingBuy Company Overview Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. Read More Semler Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks52nd Percentile Overall ScoreSMLR MarketRank™: Semler Scientific scored higher than 52% of companies evaluated by MarketBeat, and ranked 549th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingBuy Consensus RatingSemler Scientific has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageSemler Scientific has only been the subject of 2 research reports in the past 90 days.Read more about Semler Scientific's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Semler Scientific is -14.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Semler Scientific is -14.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSemler Scientific has a P/B Ratio of 1.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Semler Scientific's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted25.29% of the float of Semler Scientific has been sold short.Short Interest Ratio / Days to CoverSemler Scientific has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Semler Scientific has recently increased by 8.46%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSemler Scientific does not currently pay a dividend.Dividend GrowthSemler Scientific does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted25.29% of the float of Semler Scientific has been sold short.Short Interest Ratio / Days to CoverSemler Scientific has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Semler Scientific has recently increased by 8.46%, indicating that investor sentiment is decreasing significantly. News and Social Media3.0 / 5News Sentiment0.45 News SentimentSemler Scientific has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.07 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Semler Scientific this week, compared to 5 articles on an average week.Search Interest11 people have searched for SMLR on MarketBeat in the last 30 days. This is an increase of 120% compared to the previous 30 days.MarketBeat Follows2 people have added Semler Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Semler Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders30.20% of the stock of Semler Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions49.37% of the stock of Semler Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Semler Scientific's insider trading history. Receive SMLR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address SMLR Stock News HeadlinesRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJuly 25 at 6:43 PM | prnewswire.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 24 at 11:40 PM | globenewswire.comI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.July 26 at 2:00 AM | Timothy Sykes (Ad)Semler Scientific Acquires Bitcoin Worth Over $20 Million, Total Holdings Cross 5,000 BTCJuly 24 at 11:17 AM | msn.comSemler Scientific® Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial ResultsJuly 21, 2025 | prnewswire.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 20, 2025 | globenewswire.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJuly 18, 2025 | prnewswire.comSemler Scientific Becomes 14th-Largest Public Bitcoin Holder After $25M BTC BuyJuly 18, 2025 | finance.yahoo.comSee More Headlines SMLR Stock Analysis - Frequently Asked Questions How have SMLR shares performed this year? Semler Scientific's stock was trading at $54.00 at the start of the year. Since then, SMLR stock has decreased by 29.5% and is now trading at $38.08. How were Semler Scientific's earnings last quarter? Semler Scientific Inc. (NASDAQ:SMLR) announced its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The company earned $8.84 million during the quarter. Semler Scientific had a negative net margin of 60.69% and a positive trailing twelve-month return on equity of 19.75%. Read the conference call transcript. Who are Semler Scientific's major shareholders? Top institutional investors of Semler Scientific include Deltec Asset Management LLC (0.74%), Exchange Traded Concepts LLC (0.51%) and SummerHaven Investment Management LLC (0.17%). Insiders that own company stock include Eric Semler and Douglas Murphy-Chutorian. View institutional ownership trends. How do I buy shares of Semler Scientific? Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Semler Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Semler Scientific investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Arista Networks (ANET) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings5/13/2025Today7/26/2025Next Earnings (Estimated)8/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:SMLR CIK1554859 Webwww.semlerscientific.com Phone877-774-4211FaxN/AEmployees120Year FoundedN/APrice Target and Rating Average Price Target for Semler Scientific$89.00 High Price Target$101.00 Low Price Target$71.00 Potential Upside/Downside+133.7%Consensus RatingBuy Rating Score (0-4)3.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($2.61) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$40.90 million Net Margins-60.69% Pretax Margin-70.66% Return on Equity19.75% Return on Assets15.47% Debt Debt-to-Equity Ratio0.59 Current Ratio0.52 Quick Ratio0.51 Sales & Book Value Annual Sales$49.23 million Price / Sales10.67 Cash Flow$4.38 per share Price / Cash Flow8.69 Book Value$24.90 per share Price / Book1.53Miscellaneous Outstanding Shares13,788,000Free Float9,624,000Market Cap$525.05 million OptionableNot Optionable Beta1.39 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:SMLR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.